Benefit on QoL with revascularization proportional to severity of angina symptoms
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- AHA 2019A rise in adverse clinical events with NOAC-regime after TAVR resulted in termination of trial
Prof. Freek Verheugt, MD
Prof. Mikhail Kosiborod
Scott Solomon, MD